GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

NCT02360111 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Leukemia
Myelodysplastic Syndrome
Non-Hodgkin's Lymphoma

Interventions

DRUG: Cyclophosphamide

Sponsor

Memorial Sloan Kettering Cancer Center